UK Markets closed
  • NIKKEI 225

    28,257.25
    -76.27 (-0.27%)
     
  • HANG SENG

    24,112.78
    -105.25 (-0.43%)
     
  • CRUDE OIL

    86.82
    +1.39 (+1.63%)
     
  • GOLD FUTURES

    1,814.00
    +1.60 (+0.09%)
     
  • DOW

    35,368.47
    -543.34 (-1.51%)
     
  • BTC-GBP

    31,164.13
    -31.64 (-0.10%)
     
  • CMC Crypto 200

    1,009.15
    -0.24 (-0.02%)
     
  • Nasdaq

    14,506.90
    -386.86 (-2.60%)
     
  • ^FTAS

    4,263.04
    -29.54 (-0.69%)
     

Global Clinical Chemistry Rapid Tests and POC Devices Pipeline Market Landscape Report 2021 - ResearchAndMarkets.com

·3-min read

DUBLIN, December 08, 2021--(BUSINESS WIRE)--The "Clinical Chemistry Rapid Tests and POC - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information about the Clinical Chemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clinical chemistry rapid tests provide the test results immediately. These tests are used in low resource settings with the help of test strips, tablets and solutions. Clinical chemistry PoC diagnostics are used to determine the concentration or activity of blood gas, electrolytes, metabolites, enzymes, carbohydrates, proteins, lipids and small molecules.

Scope

  • Extensive coverage of the Clinical Chemistry Rapid Tests & POC under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Clinical Chemistry Rapid Tests & POC and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Clinical Chemistry Rapid Tests & POC Overview

3 Products under Development

3.1 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development

3.2 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Territory

3.3 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Regulatory Path

3.4 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date

4 Clinical Chemistry Rapid Tests & POC - Pipeline Products under Development by Companies

4.1 Clinical Chemistry Rapid Tests & POC Companies - Pipeline Products by Stage of Development

4.2 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development

5 Clinical Chemistry Rapid Tests & POC Companies and Product Overview

6 Clinical Chemistry Rapid Tests & POC- Recent Developments

7 Appendix

Companies Mentioned

  • Abreos Biosciences Inc

  • Acetaminophen Toxicity Diagnostics, LLC

  • Affinergy LLC

  • Am Biotechnologies, LLC

  • AnaZyme LLC

  • Angle Biosciences Inc

  • Augurix SA

  • Baebies Inc

  • Base Pair Biotechnologies Inc

  • Biocross SL

  • Bioftalmik Applied Research

  • Biotech Resources Aust Pty Ltd

  • Boditech Med Inc

  • Burnet Institute

  • Calmark Sweden AB

  • Cambridge Diagnostic Imaging Ltd

  • Carclo Diagnostic Solutions Ltd

  • CardioGenics Inc

  • Cellex Inc

  • Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine

  • Claremont BioSolutions

  • Columbia University

  • CTK Biotech Inc

  • DiaSys Diagnostic Systems GmbH

  • Edan Instruments Inc

  • Enesi Pharma Ltd

  • Enigma Diagnostics Ltd (Inactive)

  • Erytech Pharma SA

  • FK-Biotecnologia SA

  • Foundation for Innovative New Diagnostics

  • Gendiag

  • Group K Diagnostics

  • Guangzhou Wondfo Biotech Co Ltd

  • Instrumentation Laboratory Co

  • Integrated Diagnostics Inc (Inactive)

  • IntraMed Diagnostics, LLC

  • IPI Singapore

  • IR2Dx Inc.

  • Iron Horse Diagnostics, Inc.

  • Kenyatta University

  • Magee-Womens Research Institute

  • Massachusetts Institute of Technology

  • Medical University of South Carolina

  • MiCo BioMed Co Ltd

  • Monash University

  • Montana State University

  • NanoSpeed Diagnostics Inc

  • Novartis AG

  • Ohmx Corp

  • OPKO Health Inc

  • Oxford Immunotec Ltd

  • P2D Inc

  • Pennsylvania State University

  • Philips Healthcare

  • Pop Test LLC

  • PortaScience Inc

  • ProciseDx LLC

  • Quidel Corp

  • SaltCheck Inc (Inactive)

  • Seattle Children's Hospital

  • SenGenix Inc

  • SuperNova Diagnostics, Inc.

  • Systagenix Wound Management Ltd

  • The University of New South Wales press Limited

  • Thermo Fisher Scientific Inc

  • Trivitron Healthcare Pvt Ltd

  • Universal Biosensors Inc

  • University of Edinburgh

  • University of South Australia

  • UrSure Inc

For more information about this report visit https://www.researchandmarkets.com/r/5vl9nz

View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005767/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting